Association of immune-related adverse events (irAEs) with improved clinical outcome in sarcoma patients treated with immune checkpoint blockade (ICB).

Evan Rosenbaum, William D. Tap, Ciara M. Kelly et al.|Journal of Clinical Oncology|2020

Cited by 2